Medicinal Products

Softinelle P 0,02 mg/3 mg filmom obložene tablete

Name Softinelle P 0,02 mg/3 mg filmom obložene tablete
Marketing Authorisation Number HR-H-705823367
Active Substance etinilestradiol
drospirenon
Composition 24 svjetloružičaste filmom obložene tablete: svaka filmom obložena tableta sadrži 0,02 mg etinilestradiola i 3 mg drospirenona 4 bijele placebo filmom obložene tablete ne sadrže djelatne tvari
Pharmaceutical Form filmom obložena tableta
Manufacturer Pliva Hrvatska d.o.o., Zagreb, Hrvatska
Marketing Authorisation Holder Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka
Marketing Authorisation Date 06.07.2021
MA Period of Validity unlimited
MA Revocation Date 08.04.2025*
Classification Number UP/I-530-09/17-02/400
Registration Number 381-12-01/70-21-21
Prescription Medicinal product subject to medical prescription
Type of prescription ponovljivi recept
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code G03AA12
Marketing status trajni prekid opskrbe
SmPC download
PL download
Educational materials
for healthcare professionals
Lista Provjere liječnici
Educational materials
for patients / caregivers
Važne informacije za korisnicu

*Note

Marketing authorisation has been revoked by request of the marketing authorisation holder. In accordance with Article 113 of Medicinal Products Act (Official Gazette No. 76/13), only a medicinal product in respect of which a marketing authorisation has been granted by the Agency for Medicinal Products and Medical Devices or the European Commision, and a medicinal product in respect of which an authorisation for parallel import or parallel distribution has been granted may be placed on the market of the Republic of Croatia. By way of derogation from this provision, a batch of medicinal product may be on the market for no longer than 18 months following the expiry of revocation of the marketing authorisation, unless its shelf life expires first.

Packaging

Back